{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:25:11Z","timestamp":1782854711249,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1124\/dmd.113.054718","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T03:59:51Z","timestamp":1390535991000},"page":"529-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["UGT2B Gene Expression Analysis in Multiple Tobacco Carcinogen-Targeted Tissues"],"prefix":"10.1016","volume":"42","author":[{"given":"Nathan R.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.054718_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2133\/dmpk.22.391","article-title":"Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers","volume":"22","author":"Aueviriyavit","year":"2007","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.113.054718_bib2","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1158\/0008-5472.CAN-08-4143","article-title":"Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype","volume":"69","author":"Balliet","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.054718_bib3","doi-asserted-by":"crossref","first-page":"32852","DOI":"10.1074\/jbc.M305361200","article-title":"Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme","volume":"278","author":"Barbier","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.054718_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/mol.104.003863","article-title":"Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha","volume":"67","author":"Barbier","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.054718_bib5","doi-asserted-by":"crossref","first-page":"22855","DOI":"10.1074\/jbc.271.37.22855","article-title":"Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids","volume":"271","author":"Beaulieu","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.054718_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/bbrc.1998.8908","article-title":"Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11","volume":"248","author":"Beaulieu","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.113.054718_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0960-0760(97)00183-0","article-title":"Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues","volume":"65","author":"B\u00e9langer","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/dmd.113.054718_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tem.2003.10.005","article-title":"Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans","volume":"14","author":"B\u00e9langer","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/dmd.113.054718_bib9","first-page":"526","article-title":"Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1","volume":"56","author":"Bernard","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.054718_bib10","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1158\/0008-5472.CAN-08-3708","article-title":"Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites","volume":"69","author":"Blevins-Primeau","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.054718_bib11","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.054718_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/FPC.0b013e3282f4dbdd","article-title":"Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines","volume":"18","author":"Chen","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.113.054718_bib13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/dmd.107.019406","article-title":"Glucuronidation of tobacco-specific nitrosamines by UGT2B10","volume":"36","author":"Chen","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.054718_bib14","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1158\/0008-5472.CAN-09-4582","article-title":"Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.054718_bib15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-3565(24)29222-3","article-title":"Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms","volume":"299","author":"Court","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.054718_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/00498254.2011.618954","article-title":"Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues","volume":"42","author":"Court","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.054718_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00204-006-0135-8","article-title":"Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver","volume":"81","author":"Elovaara","year":"2007","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.113.054718_bib18","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1021\/pr4004213","article-title":"Targeted quantitative proteomics for the analysis of 14 UGT1As and -2Bs in human liver using NanoUPLC-MS\/MS with selected reaction monitoring","volume":"12","author":"Fallon","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1124\/dmd.113.054718_bib19","first-page":"1978","article-title":"Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes","volume":"62","author":"Fang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.054718_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-5793(89)80111-5","article-title":"Expression of a human liver cDNA encoding a UDP-glucuronosyltransferase catalysing the glucuronidation of hyodeoxycholic acid in cell culture","volume":"243","author":"Fournel-Gigleux","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.113.054718_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/1055-9965.EPI-06-0823","article-title":"The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer","volume":"16","author":"Gallagher","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1124\/dmd.113.054718_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/dmd.106.012203","article-title":"Isolation of the UDP-glucuronosyltransferase 1A3 and 1A4 proximal promoters and characterization of their dependence on the transcription factor hepatocyte nuclear factor 1alpha","volume":"35","author":"Gardner-Stephen","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.054718_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2310\/6670.2004.00035","article-title":"Presidential address: The state of the union of vascular surgery, 2004","volume":"12","author":"Gregory","year":"2004","journal-title":"Vascular"},{"key":"10.1124\/dmd.113.054718_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/tx980005y","article-title":"Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines","volume":"11","author":"Hecht","year":"1998","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.113.054718_bib25","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/jnci\/djm115","article-title":"UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters","volume":"99","author":"Hoskins","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/dmd.113.054718_bib26","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0026-895X(24)26503-2","article-title":"Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter","volume":"57","author":"Ishii","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.054718_bib27","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1124\/dmd.109.027227","article-title":"Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers","volume":"37","author":"Izukawa","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.054718_bib28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.112.192658","article-title":"Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activity","volume":"342","author":"Jones","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.054718_bib29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/dmd.30.6.694","article-title":"Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance","volume":"30","author":"Kemp","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.054718_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.fpc.0000175596.52443.ef","article-title":"Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes","volume":"15","author":"Lazarus","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.113.054718_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00008571-199708000-00007","article-title":"Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene","volume":"7","author":"L\u00e9vesque","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.113.054718_bib32","first-page":"207","article-title":"Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene","volume":"9","author":"L\u00e9vesque","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.113.054718_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.113.054718_bib34","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/sj.onc.1209375","article-title":"Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer","volume":"25","author":"Nagar","year":"2006","journal-title":"Oncogene"},{"key":"10.1124\/dmd.113.054718_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/FPC.0b013e32830500c9","article-title":"Genetic polymorphisms in the 5\u2032-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation","volume":"18","author":"Nakamura","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.113.054718_bib36","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1124\/dmd.108.021428","article-title":"Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines","volume":"36","author":"Nakamura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.054718_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/dmd.108.023598","article-title":"Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction","volume":"37","author":"Ohno","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.054718_bib38","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/tx200178v","article-title":"Characterization of dibenzo[a,l]pyrene-trans-11,12-diol (dibenzo[def,p]chrysene) glucuronidation by UDP-glucuronosyltransferases","volume":"24","author":"Olson","year":"2011","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.113.054718_bib39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2125.2007.02923.x","article-title":"Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes","volume":"64","author":"Peterkin","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.113.054718_bib40","doi-asserted-by":"crossref","first-page":"25636","DOI":"10.1016\/S0021-9258(19)74437-8","article-title":"Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4","volume":"268","author":"Pillot","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.054718_bib41","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0090-9556(24)15084-2","article-title":"O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9","volume":"28","author":"Ren","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.054718_bib42","first-page":"6912","article-title":"Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines","volume":"48","author":"Rivenson","year":"1988","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.054718_bib43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/mol.52.2.212","article-title":"Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue","volume":"52","author":"Strassburg","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.054718_bib44","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.1074\/jbc.273.15.8719","article-title":"Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8","volume":"273","author":"Strassburg","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.054718_bib45","doi-asserted-by":"crossref","first-page":"36164","DOI":"10.1074\/jbc.M002180200","article-title":"Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine","volume":"275","author":"Strassburg","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.054718_bib46","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/bcr1539","article-title":"Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants","volume":"8","author":"Sun","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1124\/dmd.113.054718_bib47","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1124\/dmd.107.017145","article-title":"Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases","volume":"35","author":"Sun","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.054718_bib48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/FPC.0b013e32833b04af","article-title":"Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogenetics","volume":"20","author":"Sun","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.113.054718_bib49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.113.054718_bib50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0026-895X(24)12228-6","article-title":"Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract","volume":"59","author":"Tukey","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.054718_bib51","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/endo.142.2.7958","article-title":"Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members","volume":"142","author":"Turgeon","year":"2001","journal-title":"Endocrinology"},{"key":"10.1124\/dmd.113.054718_bib52","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1194\/jlr.M300010-JLR200","article-title":"Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases","volume":"44","author":"Turgeon","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1124\/dmd.113.054718_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0773.1998.tb01401.x","article-title":"Effect of cigarette smoke on UDP-glucuronosyltransferase activity and cytochrome P450 content in liver, lung and kidney microsomes in mice","volume":"82","author":"Villard","year":"1998","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/dmd.113.054718_bib54","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1158\/0008-5472.CAN-10-1087","article-title":"Tobacco and cancer: an American Association for Cancer Research policy statement","volume":"70","author":"Viswanath","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.054718_bib55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/dmd.32.1.72","article-title":"Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4","volume":"32","author":"Wiener","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.054718_bib56","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/0008-5472.CAN-03-3219","article-title":"Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes","volume":"64","author":"Wiener","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.054718_bib57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ygeno.2004.06.011","article-title":"Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15","volume":"84","author":"Wilson","year":"2004","journal-title":"Genomics"},{"key":"10.1124\/dmd.113.054718_bib58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1389200054633853","article-title":"Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases","volume":"6","author":"Zhou","year":"2005","journal-title":"Curr Drug Metab"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624113980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624113980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.054718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:34:19Z","timestamp":1739907259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624113980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0090955624113980"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.054718","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UGT2B Gene Expression Analysis in Multiple Tobacco Carcinogen-Targeted Tissues","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.054718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}